Overview

Exploring Biomarkers for Depression

Status:
Completed
Trial end date:
2017-10-14
Target enrollment:
Participant gender:
Summary
The purpose of this research is to explore objective biomarkers in voice, physiological, motor, and brain imaging signals that may one day be used to complement clinical evaluation and treatment of depression.
Details
Lead Sponsor:
Wyss Institute at Harvard University
Collaborators:
Martinos Center for Biomedical Imaging
Massachusetts General Hospital
Massachusetts Institute of Technology
Treatments:
Citalopram
Dexetimide